| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $237K | +86.9% |
| R&D Expense | $154K | -27.6% |
| SG&A Expense | $59K | — |
| Operating Income | -$417K | +39.3% |
| Pre-tax Income | -$668K | -157.8% |
| Net Income | -$668K | -157.8% |
| EPS (Basic) | -$0.16 | -155.2% |
| EPS (Diluted) | -$0.16 | -155.2% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $716 | -99.4% |
| Accounts Receivable | $95K | — |
| Current Assets | $143K | +9.4% |
| Total Assets | $161K | -54.4% |
| Current Liabilities | $5.4M | +1.3% |
| Total Liabilities | $5.4M | -1.5% |
| Stockholders' Equity | -$5.2M | -2.2% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$752K | -332.1% |
| Financing Cash Flow | $631K | +159.0% |